1. Introduction {#sec1-cells-08-01117}
===============

Chronic liver diseases (CLD) can lead to hepatic dysfunction with organ failure. Early studies in humans showed that in conditions of submassive necrosis, reactive ductules and intermediate hepatocyte-like cells originate from the activation and differentiation of putative progenitor cells \[[@B1-cells-08-01117],[@B2-cells-08-01117]\]. In such conditions, adult biliary epithelial cells (BECs) are believed to activate and differentiate, thereby providing an endogenous back-up system for replenishing hepatocytes and cholangiocytes when the regenerative capabilities of these cells are impaired \[[@B3-cells-08-01117],[@B4-cells-08-01117],[@B5-cells-08-01117]\]. When the biliary regeneration is compromised, hepatocytes can also provide a backup mechanism by transdifferentiating into BECs \[[@B6-cells-08-01117],[@B7-cells-08-01117]\].

Due to their capacity for long-term expansion, chromosomal stability and their differentiation potential towards hepatocytes, such BECs could provide an exciting alternative over primary hepatocytes for toxicological studies and use in regenerative medicine \[[@B8-cells-08-01117]\]. Still, it is unclear whether BECs significantly contribute to liver regeneration. Studies based on in vivo lineage tracing in mice \[[@B9-cells-08-01117],[@B10-cells-08-01117]\] initially revealed that only a limited percentage of BEC-derived hepatocytes could be detected during liver regeneration, suggesting a low contribution of BECs. Later studies show that, under very specific liver injury conditions in the mouse, BECs can significantly contribute to the regeneration of the liver \[[@B11-cells-08-01117],[@B12-cells-08-01117]\]. In contrast, other studies have shown that inhibition of BEC regeneration impairs liver recovery and decreases survival \[[@B13-cells-08-01117],[@B14-cells-08-01117]\].

The functionality of BECs can be studied by analyzing their transcriptome after isolation from healthy and injured mouse livers due to dietary supplements that result in chronic liver injury; the DDC (3,5-diethoxycarbonyl-1,4-dihydrocollidine) \[[@B15-cells-08-01117]\] and CDE (choline-deficient, ethionine-supplemented) \[[@B16-cells-08-01117]\] diets are the most frequently used models to establish an activation of the BECs (also known as a ductular reaction). The DDC diet is metabolized by hepatocytes into toxic protoporphyrins that are secreted into the bile ducts leading to cholangitis. This results in BEC expansion around the portal vein and differentiation into cholangiocytes \[[@B17-cells-08-01117]\]. A CDE diet results in hepatic damage with the formation of a ductular reaction going from the portal vein to the parenchyma and BEC differentiation towards hepatocytes \[[@B16-cells-08-01117]\]. BECs that can activate are sometimes also referred to as liver progenitor cells. In this manuscript we will refrain from using liver progenitor cells as a term and instead will refer to quiescent and activated BECs, depending on the state of the livers from which the BECs were isolated (healthy vs. diseased). For the isolation of BECs, surface markers \[[@B18-cells-08-01117],[@B19-cells-08-01117]\], functional assays \[[@B20-cells-08-01117],[@B21-cells-08-01117]\] or BEC reporter mice \[[@B10-cells-08-01117],[@B22-cells-08-01117],[@B23-cells-08-01117]\] are popular methods. While many studies have generated transcriptome profiles of BECs, isolated using different approaches from different mouse injury models ([Table 1](#cells-08-01117-t001){ref-type="table"}), so far, no comparative study has been conducted to compare gene signatures of human and mouse BECs. It is not unlikely that the use of different BEC isolation techniques has led to the isolation of subsets of BECs, which can lead to contradicting results if one considers them as the same.

An important hurdle to tackle in such a comparative study is that none of the publicly available transcriptome data sets of primary BECs use the same BEC marker or reporter gene for the isolation these cells. Indeed, Hnf1β \[[@B10-cells-08-01117]\], Mic1 1c3 \[[@B18-cells-08-01117]\] (further referred as Mic1c3), Foxl1 \[[@B22-cells-08-01117]\], Lgr5 \[[@B23-cells-08-01117]\] and Epcam \[[@B24-cells-08-01117]\] are all used to isolate BECs, but until recently there were no independent studies that confirmed any of these gene expression profiles. The Hnf1β^+^-, Foxl1^+^- and Lgr5^+^- BECs were isolated based on lineage tracing whereas Mic1c3^+^- and Epcam^+^-BECs were isolated based on their expression on the surface of these cells. One has to note that Hnf1β, Mic1c3 and Epcam are expressed in cholangiocytes as well as in quiescent BECs, while Foxl1 and Lgr5 are mainly expressed in activated BECs \[[@B10-cells-08-01117],[@B18-cells-08-01117],[@B22-cells-08-01117],[@B23-cells-08-01117],[@B24-cells-08-01117]\]. In addition, Foxl1 and Mic1c3 have been used to isolate activated BECs from DDC-injured livers, while Hnf1β positive cells were isolated from both CDE and DDC injured livers ([Table 1](#cells-08-01117-t001){ref-type="table"}). Other toxin-based models to study BEC biology have rarely been used to isolated BECs from, with exception of Lgr5^+^ cells isolated after a single CCl~4~ injection \[[@B23-cells-08-01117]\].

In a previous study, we reported on the first RNA sequencing-based transcriptome profiles of BECs isolated from alcoholic steatohepatitis patients through EpCAM- or TROP2-based FACS sorting (respectively epithelial cell adhesion molecule (TACSTD1) and trophoblast antigen 2 (TACSTD2) \[[@B25-cells-08-01117]\]. TROP-2 is a relatively new epithelial marker and is specifically expressed by activated progenitor cells in mouse models of liver disease \[[@B19-cells-08-01117]\]. Epcam is a well-established BEC marker which identifies cholangiocytes as well as BECs in mice and humans \[[@B26-cells-08-01117]\].

In this study, we performed a meta-analysis on gene expression data sets of both human and mouse BECs and created unique signatures for quiescent and activated BECs. Gene set enrichment analysis using these BEC signatures revealed an enrichment in livers of alcoholic steatohepatitis (ASH), non-alcoholic steatohepatitis (NASH) and primary sclerosing cholangitis (PSC) suggesting that these diseases are accompanied by a strong BEC activation. Finally, a selection of our BEC gene signatures can be used to identify quiescent and activated BECs in single cell RNA sequencing (scRNA seq) data sets.

2. Materials and Methods {#sec2-cells-08-01117}
========================

2.1. Source of Gene Expression Data {#sec2dot1-cells-08-01117}
-----------------------------------

We searched for publicly available transcriptomic data sets of BECs (see [Table 1](#cells-08-01117-t001){ref-type="table"}). We included only microarray data for mouse BECs, with at least two biological repeats, and using one of the three most widely used microarray platforms (Agilent 014868, Mouse 430_2 and Mogene 2.0st) so as to simplify the experiment. We avoided including more microarray platforms to avoid loss of genes due to mismatched annotation between the different platforms.

All microarray and RNA seq data used in this study are publicly available and described in [Table 1](#cells-08-01117-t001){ref-type="table"} and [Table 2](#cells-08-01117-t002){ref-type="table"}. Raw microarray files were downloaded from NCBI (<https://www.ncbi.nlm.nih.gov/geo>) and imported into RStudio (<https://www.rstudio.com>). For human BEC RNA sequencing data, normalized count files were used from Ceulemans et al. ([Table 1](#cells-08-01117-t001){ref-type="table"}) \[[@B25-cells-08-01117]\]. BEC scRNA seq data was used from Pepe-Mooney et al., 2019 (GSE125688) and Azarina et al., 2019 (GSE124395) \[[@B27-cells-08-01117],[@B28-cells-08-01117]\]. [Supplementary Table S1](#app1-cells-08-01117){ref-type="app"} shows a list of samples that refer to quiescent or activated BECs.

2.2. Microarray Data Preparation {#sec2dot2-cells-08-01117}
--------------------------------

Microarray date sets were imported separately in RStudio and normalized using Robust Multiarray Averaging using R packages "affy" \[[@B31-cells-08-01117]\] and "limma" \[[@B32-cells-08-01117]\] and duplicated gene symbols were removed. Next, all datasets were pooled together based on their gene symbol and normalized a second time to decrease batch effects using Cycle Loess algorithm. Correlation analysis is performed on merged data with tSNE plot (R package "Rtsne") and Pearson correlation heatmap in RStudio.

2.3. Generation of BEC Gene Signatures {#sec2dot3-cells-08-01117}
--------------------------------------

First, mouse BEC transcriptome data was compared to healthy liver transcriptome data and genes were selected by a fold change larger than 8 and corrected *p* value lower than 0.05 using a Benjamini--Hochberg test. Next, genes were selected by comparing BEC transcriptomes to multiple cell types with criteria used in Friedmann et al., (fold change and *p* value) \[[@B33-cells-08-01117]\]. BEC signatures were obtained by merging both gene sets with those of human BEC signatures from Ceulemans et al. \[[@B25-cells-08-01117]\] using Venn diagrams (R package "VennDiagram").

2.4. Gene Set Enrichment Analysis {#sec2dot4-cells-08-01117}
---------------------------------

Gene set enrichment analysis (GSEA) analysis was performed on normalized intensity values (microarray) or counts (RNA seq, transcripts per million) by comparing healthy livers (mouse data) or injured livers (human data) versus BEC transcriptomes. All Hallmark pathways were analyzed, and false discovery rate (FDR) scores were imported into RStudio to visualize, using heatmaps (R package "caret"). Significantly enriched pathways were based on positive NES score and FDR \< 0.25 in at least one population. GSEA analysis to test BEC signatures were visualized using R package "circlize" by displaying -log(FDR) with a maximum -log(FDR) equal to 4 (FDR \< 0.0001) for optimal visualization purposes. The direction of arrows represents enrichment of a signature towards cell types or liver tissues. Size of the arrow represents -log(FDR).

2.5. Gene Ontology Analysis {#sec2dot5-cells-08-01117}
---------------------------

GO analysis from quiescent and activation BEC gene signature was obtained using R package "clusterProfiles" and human database from R package "AnnotationHub". All biological processes were analyzed with p cutoff of 0.05. GO were visualized using the "dotplot" function in clusterProfiles.

2.6. Single Cell Signature Explorer {#sec2dot6-cells-08-01117}
-----------------------------------

ScRNA seq data of BECs and Hepatocytes were downloaded from GEO database (GSE125688) and imported into RStudio. TSNE plots were created using "Seurat" packages \[[@B34-cells-08-01117]\]. Gene signature scores were calculated and visualized using "Single-Cell Signature Explorer" (<https://sites.google.com/site/fredsoftwares/products/single-cell-signature-explorer>). Briefly, gene signature scores are computed by Single-Cell Signature Score in linux. TSNE1 and tSNE2 values created within Seurat are merged together with signature score for each cell using Single-Cell Signature Merger and imported in RStudio. Single-Cell Signature Viewer, a shiny app (<https://shiny.rstudio.com>), was used to visualize signature scores on tSNE plots with adjustable scale bar.

3. Results {#sec3-cells-08-01117}
==========

3.1. BEC Transcriptome Profiles Are Highly Affected by the Microarray Platform and Markers Used for Isolation {#sec3dot1-cells-08-01117}
-------------------------------------------------------------------------------------------------------------

To establish comparable mouse BEC gene expression data sets, we first normalized each set separately and then pooled all sets together and eventually normalized the complete pooled set to minimize batch effects ([Figure 1](#cells-08-01117-f001){ref-type="fig"}A). To be able to merge all of the microarrays, we first had to exclude some genes, for several reasons. Each microarray platform detects more than 20,000 genes by using probes that can bind to specific genes or even multiple genes. In our analysis, we first discarded probes that bind on multiple genes and afterwards discarded other genes that are not detected by all microarray platforms. We also noted that we lost several genes because multiple microarray platforms annotate some genes with different gene symbols. Finally, by pooling all microarrays, we obtained a dataset that contained 12,873 genes.

We first compared the expression profiles of freshly isolated mouse BECs \[[@B10-cells-08-01117],[@B18-cells-08-01117],[@B22-cells-08-01117],[@B23-cells-08-01117],[@B24-cells-08-01117],[@B29-cells-08-01117]\] with four BEC cell lines \[[@B30-cells-08-01117]\] and healthy liver transcriptome data \[[@B30-cells-08-01117]\]. Multidimensional reduction analysis, presented in a t-distributed stochastic neighbor embedding (t-SNE) plot, showed that these three groups were clustered separately from each other ([Figure 1](#cells-08-01117-f001){ref-type="fig"}B). We observed that within the primary BEC group, quiescent and activated BECs isolated using the same approach, could not be distinguished from each other (triangles cluster with circles of the same color; [Figure 1](#cells-08-01117-f001){ref-type="fig"}B). Furthermore, it was striking to see that Hnf1b^+^ and EpCam^+^ BEC profiles were separated from the other primary BECs in this tSNE plot. This was confirmed by Pearson correlation analyses ([Figure 1](#cells-08-01117-f001){ref-type="fig"}C); Epcam^+^ BECs cluster together with BEC cell lines and healthy livers while Hnf1β^+^ cells are again separated from these. A closer look at the platform taught us that Epcam^+^ BECs and the BEC cell lines were analyzed on the same Agilent platform, while Hnf1β^+^ cells were the only BECs analyzed with the Affimetrix (mogene 2.0 array). Together, this analysis confirms that the isolation method (or experimenter) and array platforms used are very strong confounders when different data sets need to be compared \[[@B35-cells-08-01117],[@B36-cells-08-01117]\].

3.2. Meta-Analysis Confirms the Validity of Most BEC-Specific Genes {#sec3dot2-cells-08-01117}
-------------------------------------------------------------------

Despite these platform- and isolation-specific effects, we wanted to know whether the primary mouse and human BEC populations are indeed enriched in commonly used BEC-specific genes. As expected, virtually all commonly used BEC markers (highlighted by Rodrigo-Torres et al. \[[@B10-cells-08-01117]\]) are highly enriched in all the different mouse and human BEC populations ([Figure 1](#cells-08-01117-f001){ref-type="fig"}D). The only exception is the Lgr5^+^ BEC population isolated from CCl~4~-treated mice, which suggests that Lgr5^+^ cells isolated from these livers are not similar to any of the other BECs isolated through other methods from other liver injury models.

The role of BECs in healthy and diseased livers has been intensively studied by lineage tracing experiments in mice using BEC-specific reporter mice, such as Krt19, Sox9, Foxl1, Lgr5, Spp1 (Opn) or Hnf1β \[[@B9-cells-08-01117],[@B12-cells-08-01117],[@B14-cells-08-01117],[@B22-cells-08-01117],[@B23-cells-08-01117],[@B37-cells-08-01117]\]. We therefore also analyzed their gene expression in these human and mouse BEC populations. KRT19, SOX9, SPP1 and HNF1β are greatly enriched in almost all mouse and human BEC populations confirming that these genes are indeed good candidates to be used as BEC-specific driver genes. Lgr5^+^ BECs do not show enriched expression of these genes and even under represents SOX9, suggesting again that Lgr5 positivity does not identify a traditional BEC population ([Figure 2](#cells-08-01117-f002){ref-type="fig"}). This notion is strengthened by Lgr5 gene expression, which is only enriched in the Lgr5^+^ BEC population and not in other BEC populations. In contrast, the mouse Epcam^+^ population also expresses poorly SOX9 and HNF1β but the Epcam gene is highly expressed in all human and mouse BEC populations. A possible explanation could be the isolation procedure and analysis platform used, because Epcam positivity is probably the best established method to isolate BECs by flow cytometry \[[@B8-cells-08-01117],[@B14-cells-08-01117]\].

Other frequently used surface markers to isolate BECs, such as PROM1 (aka CD133) and TROP2 are enriched in most BEC populations as well. Although TROP2 is described to be only expressed in mouse activated BECs, we see high enrichment of this gene in Hnf1β and Mic1c3 isolated BECs from healthy mouse livers, suggesting that TROP2 is also expressed in quiescent BECs ([Figure 2](#cells-08-01117-f002){ref-type="fig"}). This confirms a previous study, in which TROP2 protein is indeed expressed in both quiescent and activated BECs in human livers from ASH patients \[[@B25-cells-08-01117]\].

Less popular methods to isolate BECs are functional assays, such as the side population (SP) and aldehyde dehydrogenase (ALDH) activity \[[@B20-cells-08-01117],[@B21-cells-08-01117]\]. SP is based on efflux of Hoechst by ABC transporters, while ALDH activity assays rely on the conversion of a fluorescent molecule into a negatively charged dye initiated by ALDH enzymes \[[@B21-cells-08-01117],[@B38-cells-08-01117]\]. Although these functional assays rely on protein activity, gene expression levels of both Abcc1 and Aldh1a2 are likewise enriched in human and mouse BECs ([Figure 2](#cells-08-01117-f002){ref-type="fig"}).

3.3. Pathway Analysis Reveals New Potential Pathway in BEC Activation: KRAS Signalling {#sec3dot3-cells-08-01117}
--------------------------------------------------------------------------------------

Single gene expression analysis of BEC transcriptomic profiles is a useful tool to look for biomarkers but cannot gain much insight into the function of BECs in healthy and damaged livers. Pathway analysis, on the other hand, looks at gene sets and can predict biological functions of a cell type. We used gene set enrichment analysis (GSEA) on all human and mouse BECs and made a distinction between mouse BEC cell lines, quiescent and activated BECs, and BECs isolated after different days of DDC diet (day 0, 3 and 7).

Gene expression profiles of BEC cell lines are obviously enriched in pathways that are involved in cell growth and proliferation, such as mTor and Myc signaling, mitotic spindle and G2M checkpoint control ([Figure 3](#cells-08-01117-f003){ref-type="fig"}). Most quiescent BEC populations express genes involved in Hedgehog, Notch- and TGFβ-signaling, all pathways previously described to control the BEC phenotype \[[@B39-cells-08-01117],[@B40-cells-08-01117],[@B41-cells-08-01117],[@B42-cells-08-01117],[@B43-cells-08-01117]\]. Strikingly, TNF-signaling is the only pathway that is enriched in all BEC data sets analyzed and the KRAS signaling pathway seems to be only enriched in activated BEC populations ([Figure 3](#cells-08-01117-f003){ref-type="fig"}). Note that not all pathways are enriched in both activated human and mouse BECs.

3.4. Creation of a Unique Quiescent and Activated BEC Gene Signature {#sec3dot4-cells-08-01117}
--------------------------------------------------------------------

BECs isolated using different markers have a high variety in enriched genes and pathways. Therefore, we wanted to create a unique BEC gene set that can recognize BECs, mouse or human, in any conditions. To discard genes that are effected by batch effects, we used a fold change of at least 8 times or higher since most commonly used BEC genes are at least enriched 8 times ([Figure 1](#cells-08-01117-f001){ref-type="fig"}D). We found 417 genes that were highly enriched in quiescent BECs, when comparing healthy livers, and identified 301 genes, when comparing BEC gene profiles, to the average expression of other cell types, such as immune cells, quiescent and activated stellate cells, endothelial cells, epithelial cells and hepatocytes ([Figure 4](#cells-08-01117-f004){ref-type="fig"}A,B). By merging both gene sets, we created a mouse quiescent BEC signature containing 205 genes ([Figure 5](#cells-08-01117-f005){ref-type="fig"}A). Our aim was to create a gene signature for both mouse and human BECs so we compared our mouse signature with our previously published human BEC signature \[[@B25-cells-08-01117]\]. Finally, this resulted in a signature for quiescent human and mouse BECs consisting of 50 genes predominantly involved in cell growth, extracellular matrix organization and morphogenesis ([Table 3](#cells-08-01117-t003){ref-type="table"}, [Figure 5](#cells-08-01117-f005){ref-type="fig"}B). Using the same strategy, we obtained 725 genes enriched in activated mouse BECs compared to healthy livers and 628 genes when compared to different cell types ([Figure 4](#cells-08-01117-f004){ref-type="fig"}C,D). In this comparison, we did not include Lrg5+ gene profiles since all the other mouse and human BEC populations are not enriched in LGR5 levels and the Lrg5+ population does not express the majority of typical BEC markers. When merging both gene sets (490 genes) with the human BEC signature, we obtained an activated mouse and human BEC signature of 83 genes that are mainly involved in extracellular matrix organization and tissue development ([Figure 5](#cells-08-01117-f005){ref-type="fig"}A,C, [Table 3](#cells-08-01117-t003){ref-type="table"}). Thus, we generated a quiescent and activated BEC signature containing 50 and 83 genes, respectively. Interestingly, 39 genes are present in both signatures suggesting that these are "bona fide" BEC genes and can be used to identify both quiescent and activated BECs in human and mouse.

3.5. BEC Gene Signatures As a Tool for Identification of BECs {#sec3dot5-cells-08-01117}
-------------------------------------------------------------

Gene signatures are frequently used to study functions of cells, but also to identify specific populations. Therefore, we tested our signature on BEC-like cells and compared it to two manually established BEC signatures \[[@B30-cells-08-01117],[@B44-cells-08-01117]\]. We found that only our signatures were highly enriched in undifferentiated HepaRGs (human BEC stem cell line \[[@B45-cells-08-01117]\]) when compared to hepatocytes and in fresh or cultured BECs differentiated from induced pluripotent stem cells (iPSCs) when compared to iPSCs. Note that our signatures were not, or poorly, enriched in fetal hepatocytes (versus primary hepatocytes) and differentiated HepaRGs ([Figure 6](#cells-08-01117-f006){ref-type="fig"}A).

BECs are known to be activated in many human liver diseases, such as alcoholic steatohepatitis and cirrhosis \[[@B44-cells-08-01117],[@B46-cells-08-01117]\]. We therefore compared all BEC signatures to evaluate BEC enrichment in different human liver disorders. Our results show that only our generated signatures and the previously reported signature of Sancho-Bru et al. \[[@B44-cells-08-01117]\] are able to detect BEC enrichment in alcoholic hepatitis, NASH and peribiliary sclerotic livers. Remarkably, none of the signatures can recognize BECs in peribiliary cirrhosis (PBC) livers, even though it is well known that this disease state is accompanied with activated BECs ([Figure 6](#cells-08-01117-f006){ref-type="fig"}B).

Recently, Pepe-Mooney et al. performed single cell RNA sequencing (scRNAseq, \[[@B47-cells-08-01117]\]) on BECs (Epcam^+^) and hepatocytes isolated from healthy and DDC-injured livers \[[@B27-cells-08-01117]\]. Unbiased detection of different cell populations are performed by tSNE plot and verified using well-known markers. We used their single cell transcriptome data and created a tSNE plot to verify our BEC signatures. This plot clearly presents four different groups (healthy and DDC-injured hepatocytes and BECs), which was confirmed by commonly used BEC and hepatocyte markers ([Supplementary Figure S1A](#app1-cells-08-01117){ref-type="app"}). Almost all hepatocytes expressed Cyp3a11, Cyp2e1 and albumin while the BEC fraction expressed Sox9 and Epcam. Tacstd2 (aka Trop2) was expressed only in BECs isolated from DDC-injured livers, suggesting that this fraction contains activated BECs. Instead of validating cell populations using one marker, Pont et al. designed "Single Cell Signature explorer" to calculate a signature score at the single cell level and visualize these scores on tSNE plots \[[@B48-cells-08-01117]\]. Using this tool, we calculated our activation and quiescent BEC signatures on scRNA seq data and represented them in tSNE plots ([Supplemental Figure S1B](#app1-cells-08-01117){ref-type="app"}). Our results show that our quiescent signature was enriched in most BECs isolated from healthy livers, while our activation signature was scattered between both BECs from healthy or DDC injured mice. This suggests that these signatures are not sufficiently restricted to distinguish these populations in this scRNAseq data set that only consists of BECs and hepatocytes. To establish a scRNAseq signature for BECs, we extracted genes that are mainly enriched in BECs using scRNAseq data of Aizarani et al., 2019 \[[@B28-cells-08-01117]\]. This data set contains single cell expression of BECs, hepatocytes, liver sinusoidal endothelial cells (LSECs), Kupffer cells and other immune cells, such as natural killer cells and cytotoxic T-cells ([Supplementary Figure S2](#app1-cells-08-01117){ref-type="app"}). We first extracted genes that are only expressed in human BECs with at least an average fold change of 2. By merging these genes with our quiescent and activated signature, we created a scBEC signature containing 9 genes (SOX9, MAGI1, BICC1, EPCAM, SLC5A1, DCDC2, ITGB8, KRT7 and CYR61, [Figure 5](#cells-08-01117-f005){ref-type="fig"}D, [Figure 7](#cells-08-01117-f007){ref-type="fig"}A). Next, we validated this scBEC signature in the tSNE plot of Pepe-Mooney et al. and confirmed that almost all genes were highly enriched in only quiescent as well as activated mouse BECs ([Figure 7](#cells-08-01117-f007){ref-type="fig"}B). Note that mouse BECs and hepatocytes do not express Itgb8.

4. Discussion {#sec4-cells-08-01117}
=============

BECs are intensively studied due to their potential to proliferate and differentiate into hepatocytes and cholangiocytes in vivo and in vitro. They form a type of backup system which is activated when hepatocytes no longer have the capacity to restore the liver cell mass \[[@B49-cells-08-01117],[@B50-cells-08-01117]\]. Many studies describe the isolation of BECs from healthy and injured mouse livers and performed transcriptomic analysis to gain more insight into their function and their regulation. However, from these studies it was never clear whether the different reports were actually looking at the same BEC population since different isolation techniques and liver injury models were used. We therefore compared transcriptome data of BECs isolated from different injury models using different approaches. By doing so we established gene signatures that can be used to detect the presence or enrichment of BECs in gene expression data sets obtain through either standard gene array platforms or from (sc)RNA sequencing. A final scBEC signature, which consists of BEC-related and unrelated genes, was very efficient in separating qBECs and aBECs from other liver cell types in tSNE plots obtained from scRNAseq data.

Until recently, it was not common practice to compare the gene profile data of the cell type that one wanted to report on, to gene expression data of a similar cell type reported previously by someone else. Often the data had not been deposited in a public database or there has been an embargo period to download the data. This way researchers withhold published data from direct competitors or those with contrary views. It is fortunate that this trend is changing, and we used the kindly shared data ([Table 1](#cells-08-01117-t001){ref-type="table"}) to compare the BEC gene profiles with the aim to generate a gene signature for BECs and as a result of this perhaps identify novel genes involved in BEC biology.

We found that microarray platforms and the method used to isolate the BECs have a high impact on the transcriptome data obtained. However, most BEC populations are still highly enriched in popular BEC markers such as Krt19, Epcam and Sox9, but are clearly not similar and thus could affect the conclusions drawn in these studies. The difference in gene profiles can also be explained by the fact that the isolation procedures used were all based on the enrichment by only one BEC-marker (with exception of Mic1c3). Indeed, our results suggest that isolation of BECs based on only Epcam is not a good option, because this population is poorly enriched in Sox9, Hnf1β and Abcc1. A reason for this could be that these represent rarer subtypes of BECs are more difficult to detect in bulk transcriptomic data of Epcam positive cells. However, since gene expression of Epcam itself is highly enriched in all BEC populations, we do believe that Epcam-based cell sorting is a good way to enrich for BECs, but in combination with other markers. This corroborates studies by Lu et al. who investigated multiple markers for the isolation of BECs and found that CD45^-^CD31^-^Ter119^-^Epcam^+^CD24^+^CD133^+^ cells are true biliary cells, unfortunately the authors did not perform extensive gene expression profiling \[[@B14-cells-08-01117]\].

The BEC transcriptomic data obtained from human and mouse livers clearly show differences. [Supplemental Table S2](#app1-cells-08-01117){ref-type="app"} shows a list of genes only expressed in human or mouse BECs which suggest that there are some differences between human and mouse BECs. Importantly, several papers have shown that analyzing transcriptome using RNA-seq and microarray can already result in significant differences \[[@B51-cells-08-01117],[@B52-cells-08-01117],[@B53-cells-08-01117]\]. Microarray depends on the variety of probes that can detect specific RNA molecules while RNA-seq analyses all RNAs. RNA-seq is therefore more sensitive and will find more differentially regulated genes which can result in finding different pathways. There is a platform-specific batch effect which cannot be circumvented since all quiescent mouse BECs were analyzed using different platforms. To overrule this batch effect, we included only genes in our BEC gene signatures that showed a \>8 fold enrichment over healthy livers.

One could argue that, with the introduction of scRNAseq analysis, markers for BECs are not needed anymore to carry out transcriptome profiling of BECs in healthy and diseased states. However, due to the abundance of hepatocytes, macrophages and endothelial cells in a single cell suspension of livers, one still needs to enrich for low abundance cell types to obtain sufficient cells to be sequenced. A recent publication investigated human BECs on single cell level and reported the isolation of EPCAM^+^CDH6^+^TROP2- BECs \[[@B54-cells-08-01117]\]. CDH6 is also present in our BEC gene signature, and it is clear from the scRNAseq data from Pepe-Mooney et al., 2019 \[[@B27-cells-08-01117]\] ([Figure 5](#cells-08-01117-f005){ref-type="fig"}C) that a negative selection for TROP2 would not discard many cells from an EPCAM isolation. However, by a negative selection of TROP2 one might dispose of a separate BEC population since TROP2 positive cells from alcoholic steatohepatitis livers are enriched in most BEC markers and TROP2 itself is highly enriched in almost all human and mouse BEC transcriptomes analyzed ([Figure 2](#cells-08-01117-f002){ref-type="fig"} and \[[@B19-cells-08-01117]\]).

In our efforts to identify additional BEC markers, we reviewed the expression patterns of our signature genes using the human protein atlas ([www.proteinatlas.org](www.proteinatlas.org)). Several proteins from our signatures, previously not associated with BECs, are localized to biliary epithelial cells or ductular reactions (C1orf116, CDH6, S100A6, MYO6, AKAP7 and DCDC2) and thus can be used to identify or isolate (subsets) of BEC populations ([Supplemental Figure S3](#app1-cells-08-01117){ref-type="app"}). Their localizations in the liver and their association with an BEC signature makes these proteins interesting subjects for further analysis in BEC biology. ScRNA sequencing provides much more information compared to bulk microarray or RNA sequencing because the transcriptome from every cell is analyzed separately. Still, it does not necessarily give insight into the protein production and localization of the gene of interest in the liver. A recent study combined scRNA sequencing with RNA hybridization of livers, an approach that could be used to look for RNA as a marker for BECs instead of proteins \[[@B55-cells-08-01117]\]. Cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) is another recent development in which transcriptome analysis is combined with expression of a panel of proteins at a single cell level \[[@B56-cells-08-01117]\]. With this strategy, gene expression can be related to protein expression and could perhaps lead to the identification of other membrane proteins that are strongly linked to an BEC gene profile. Of course, in the case of BECs, one would still need to enrich for an BEC-like cell before CITE-seq analysis due to the low abundance of these cells in the liver.

Merging differently isolated BEC populations can remove batch effects and therefore be more precise when performing pathway analysis. We found that the KRAS signaling pathway is enriched in BECs that are being activated that thus could be important for BEC activation. Recent studies reported that KRAS signaling is indeed important in self-renewal, proliferation and differentiation of hematopoietic and induced pluripotent stem cells \[[@B57-cells-08-01117],[@B58-cells-08-01117],[@B59-cells-08-01117]\], however further studies are needed to determine whether this pathway is also essential for BEC biology.

Gene signatures can be used to identify certain isolated cell populations. We created a quiescent and activated BEC gene signature that can recognize BEC-like cells and detect BECs in liver diseases accompanied with an activation of the BEC compartment. Interestingly, both the quiescent and activated BEC signature were equally enriched in PSC and NASH, suggests that both populations are present. There is less gene enrichment for AH and AC, which suggests less BEC expansion in these diseases or a higher variability in AH and AC. Strangely, we found no enrichment in PBC which is known to contain expanded BECs \[[@B25-cells-08-01117]\]. We also investigated whether genes of the scBEC signature could be used to examine for BEC activation in the different liver diseases. Only EPCAM, SOX9 and DCDC2 were enriched in ASH and Cirrhotic livers ([Supplemental Figure S4](#app1-cells-08-01117){ref-type="app"}). This indicates that the scBEC signature is not able to identify activated BECs in bulk transcriptomic data of diseased livers. Probably because this scBEC signature only recognizes certain subsets of activated BECs while the quiescent and activated signatures can identify higher variety of BECs.

ScRNA seq is becoming the standard when analyzing transcriptomes of specific cell population. Several recent publications performed scRNA seq to study mechanisms of BECs from injured livers \[[@B27-cells-08-01117],[@B60-cells-08-01117]\]. One of the main issues of scRNA seq is to categorize different cell clusters within a t-SNE plot. Most researchers use multiple gene markers to identify these clusters. We found that our gene signature, created by bulk microarray and RNA seq, was not able to recognize all activated BECs in a t-SNE plot representing hepatocytes and Epcam positive cells isolated from healthy and diseased mouse livers. This suggests that gene signatures might need to be re-evaluated, depending on the complexity of the scRNA sequencing data. In the example described here, we found several genes from our quiescent and activation gene signature that were only expressed in human BECs, based on tSNE plot from the data of Aizarani et al., 2019 \[[@B28-cells-08-01117]\]. However, these few genes might not be specific enough if other cell types such as hepatic stellate cells cells are included into the tSNE plot. For instance, S100A6 was recently identified as a universal marker of activated myofibroblasts \[[@B61-cells-08-01117]\]. Future scRNAseq data sets representing equal amounts of different liver cell populations in one tSNE plot will determine whether the BEC signatures that we describe here will be sufficient to identify quiescent and activated BECs in mouse or human livers.

To summarize, we describe here for, the first time, a meta-analysis on gene profiles obtained from BECs isolated from different liver injury models and human diseased livers, and analyzed by several different analysis platforms. We created a unique gene signature for the identification of BECs in bulk microarray and RNAseq data sets, but also created a gene signature that identifies both quiescent and activated BECs in a scRNA seq data set.
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The following are available online at <https://www.mdpi.com/2073-4409/8/10/1117/s1>, Figure S1 TSNE plots displaying expression of genes and gene signatures from scRNA seq data of Pepe-Mooney et al., 2019. Figure S2 TSNE plots of scRNAseq data of different cell types isolated from healthy human livers from Aizarani et al., 2019. Figure S3 Immunohistochemistry staining of new potential BEC markers from our BEC signature, obtained from protein atlas. Figure S4 Gene expression of genes in the scBEC signature on transcriptomic data of NASH, ASH, Cirrhosis and PSC. Table S1 BEC labeling based on injury model. Table S2 List of genes expressed by only human or mouse BECs.
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![Workflow and clustering of BEC transcriptome data sets. (**A**) Schematic overview of the workflow to merge microarray data from different platforms. Colored bars represent boxplots of the expression of all genes from one sample. Three colors are an example of three different datasets with multiple samples. (**B**,**C**) T-distributed stochastic neighbor embedding (t-SNE) and Pearson correlation analysis of mouse transcriptomic data from BEC cell lines, primary BECs and healthy livers. (**D**) Relative gene expression analysis (fold change, log2) of common BEC markers in primary human and mouse BECs compared to livers.](cells-08-01117-g001){#cells-08-01117-f001}

![Gene expression of popularly used BEC markers for isolation in primary human and mouse BECs. Gene expression of mouse and human livers (grey), quiescent (orange) and activated (blue) BECs. Left axis represents normalized intensity values (log2) for all mouse gene expression and right axis normalized transcript per million (log2) for human data.](cells-08-01117-g002){#cells-08-01117-f002}

![Pathway analysis of BEC populations. Gene set enrichment analysis of Hallmark pathways on transcriptomic profiles of BECs compared to healthy (mouse) or injured (human) livers. Gradient of the blue color represents positively enriched pathway (False discovery rate, FDR).](cells-08-01117-g003){#cells-08-01117-f003}

![Selection of genes enriched in BECs. Heatmap of genes enriched in BECs compared to healthy livers (**A** and **C**) or different cell types (**B** and **D**). For A only genes enriched in BECs isolated from healthy mouse livers were used while for C only genes enriched in BECs isolated from either choline-deficient, ethionine-supplemented (CDE)- or 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-treated mice.](cells-08-01117-g004){#cells-08-01117-f004}

![Generation of BEC gene signatures. (**A**) Venn diagrams of the genes enriched in BECs compared to healthy livers or different cell types and both merged gene sets compared to genes enriched in human BECs. Gene ontology (GO) analysis of quiescent (**B**) and activated (**C**) BEC gene signature. The size of the circle is correlated to the number of genes involved in that GO. The color of the circle represents significance (adjusted *p*-value) and the *x*-axis stands for gene ratio (genes within signature versus total number of genes in GO). (**D**) Venn diagram of genes enriched in quiescent and activated BECs (microarray/RNAseq) and in BECs from scRNAseq of human livers.](cells-08-01117-g005){#cells-08-01117-f005}

![BEC signatures to identify BECs. (**A** and **B**) Visual representation (chord diagram) of gene set enrichment analysis with our quiescent and activated BEC signatures, Sancho-Bru signature (2012) \[[@B44-cells-08-01117]\] and BEC cell line signature of Passman et al. 2016 \[[@B30-cells-08-01117]\] on BEC-like cells and liver diseases (AC: alcoholic cirrhosis, AH: alcoholic hepatitis, NASH: non-alcoholic steatohepatitis, PBC: peribiliary cirrhosis, PSC: primary sclerosis cholangitis). The size of the arrow presents the positive enrichment (significance, -log *p*-value).](cells-08-01117-g006){#cells-08-01117-f006}

![Validation of scBEC signature. TSNE plots of human (**A**) and mouse (**B**) liver cells from respectively Aizarani et al. 2019 \[[@B28-cells-08-01117]\] and Pepe-Mooney et al. 2019 \[[@B27-cells-08-01117]\], with expression of every single gene of the scBEC signature. Blue scale bars represent normalized counts.](cells-08-01117-g007){#cells-08-01117-f007}

cells-08-01117-t001_Table 1

###### 

Biliary epithelial cells (BEC) gene expression data.

  LPC Marker        Reference                   Healthy   Injury   Hepatocytes   Niche   Injury Model   Species   Platform   GSEA                                               
  ----------------- --------------------------- --------- -------- ------------- ------- -------------- --------- ---------- ------ ----------- ------- ----------------------- ----------------------------
  LGR5              \[[@B23-cells-08-01117]\]             x                      x       x                        x                 CCl4        Mouse   Agilent 014868 G4122F   GSE32210
  MIC1 1C3          \[[@B18-cells-08-01117]\]   x                  x             x                      x                           DDC         Mouse   Agilent 014868 G4122F   GSE29121
  HNF1b             \[[@B10-cells-08-01117]\]   x                  x             x                                                  DDC / CDE   Mouse   Mogene 2.0st            GSE51389
  Foxl1             \[[@B29-cells-08-01117]\]                      x             x                      x                           DDC         Mouse   Agilent 014868 G4122F   GSE28892
  LPC cell lines    \[[@B30-cells-08-01117]\]   x         x                                                                         None        Mouse   Mouse 430_2             GSE85114/GSE12908/GSE18269
  Side population   \[[@B25-cells-08-01117]\]                                    x       x                                   x      ASH         Human   Truseq LT               GSE102683
  EpCAM             \[[@B25-cells-08-01117]\]                                    x       x                                   x      ASH         Human   Truseq LT               GSE102683
  TROP2             \[[@B25-cells-08-01117]\]                                    x       x                                   x      ASH         Human   Truseq LT               GSE102683
  EpCAM             \[[@B24-cells-08-01117]\]   x                                                                                   None        Mouse   Mouse 430_2             GSE63793

cells-08-01117-t002_Table 2

###### 

Microarray GEO sample (GSM) number associated with cell type or tissue.

  GSM Number                                                                                           Cell Type or Tissue                              Specie
  ---------------------------------------------------------------------------------------------------- ------------------------------------------------ --------
  GSM1061907, GSM1061908, GSM686644, GSM686645                                                         Bcell                                            Mouse
  GSM1071644, GSM361592, GSM389821                                                                     platelet_megakaryocyte                           Mouse
  GSM1081398 - GSM1081400                                                                              CD8_T\_cell                                      Mouse
  GSM1129665, GSM686658, GSM686659                                                                     macrophage                                       Mouse
  GSM1214478-GSM1214480, GSM686650, GSM686651                                                          NK                                               Mouse
  GSM1232678 - GSM1232680, GSM686652, GSM686653                                                        NKT                                              Mouse
  GSM1281320 - GSM1281322, GSM525382 - GSM525384                                                       hepatocyte                                       Mouse
  GSM1301661, GSM1301662                                                                               neutrophil                                       Mouse
  GSM190795 - GSM190797, GSM598999 - GSM599002, GSM658893 - GSM658898, GSM765922 - GSM765924           epithelial                                       Mouse
  GSM216494 - GSM216497, GSM686654                                                                     erythroblast                                     Mouse
  GSM298115 - GSM298117, GSM378250 - GSM378254                                                         fetal_liver                                      Mouse
  GSM344315 - GSM344318                                                                                neutrophil                                       Mouse
  GSM547762 - GSM547766, GSM690763 - GSM690765                                                         endothelial                                      Mouse
  GSM555381 - GSM555384                                                                                CD4_T\_cell                                      Mouse
  GSM571897                                                                                            macrophage                                       Mouse
  GSM591473, GSM591475, GSM591477, GSM591480, GSM602665 - GSM602667                                    Healthy Liver                                    Mouse
  GSM686646, GSM686647                                                                                 CD4_T\_cell                                      Mouse
  GSM686648, GSM686649                                                                                 CD8_T\_cell                                      Mouse
  GSM852330 - GSM852334                                                                                Quiescent HSC                                    Mouse
  GSM852341 - GSM852343                                                                                HSC from BDL                                     Mouse
  GSM852344 - GSM852346                                                                                CCl4_HSC                                         Mouse
  GSM1557526 - GSM1557528                                                                              LPC EPCAM                                        Mouse
  GSM2257924 - GSM2257940                                                                              PIL                                              Mouse
  GSM2257941 - GSM2257944                                                                              BMOL                                             Mouse
  GSM2257945 - GSM2257947                                                                              T_LPC                                            Mouse
  GSM323977 - GSM323981                                                                                BMEL                                             Mouse
  GSM715841 - GSM715844                                                                                LPC_Foxl1_D0                                     Mouse
  GSM715856 - GSM715859                                                                                LPC_Foxl1_POS_D3                                 Mouse
  GSM715860 - GSM715863                                                                                LPC_Foxl1_POS_D7                                 Mouse
  GSM715864 - GSM715866                                                                                LPC_Foxl1_POS_D14                                Mouse
  GSM715867 - GSM715870                                                                                LPC_Foxl1_undiff                                 Mouse
  GSM721145 - GSM721149                                                                                LPC_MIC_POS_CTL                                  Mouse
  GSM721153 - GSM721156                                                                                LPC_MIC_POS_DDC                                  Mouse
  GSM1047599, GSM1047603                                                                               LPC_LGR5                                         Mouse
  GSM1244523, GSM1244525                                                                               LPC_HNF1b_POS_CDE                                Mouse
  GSM1244526 - GSM1244528                                                                              LPC_HNF1b_POS_DDC                                Mouse
  GSM1244529, GSM1244530                                                                               LPC_HNF1b_POS_CTL                                Mouse
  GSM709348 - GSM709354                                                                                Healthy Livers for ASH                           Human
  GSM709355 - GSM709369                                                                                ASH                                              Human
  GSM1974233, GSM1974234                                                                               Primary hepatocytes                              Human
  GSM1974235, GSM1974236                                                                               Fetal hepatocytes                                Human
  GSM1627740 - GSM1627773                                                                              Healthy livers for NASH                          Human
  GSM1627805, GSM1627806                                                                               Definite NASH                                    Human
  GSM155919, GSM155926 - GSM155928, GSM155947, GSM155948, GSM155961, GSM155964, GSM155988, GSM155989   Healthy livers as control for Cirrhotic livers   Human
  GSM155920 - GSM155923, GSM155931, GSM155951, GSM155952, GSM155965 - GSM155969, GSM155984             Cirrhotic livers                                 Human
  GSM2787428, GSM2787427                                                                               Human iPSC                                       Human
  GSM2787426, GSM2787425                                                                               Cultured iPSC-LPC                                Human
  GSM2787422, GSM2787421                                                                               Fresh iPSC-LPC                                   Human
  GSM456340 - GSM456342                                                                                HepaRG_diff                                      Human
  GSM456343 - GSM456345                                                                                HepaRG_undiff                                    Human
  GSM456349 - GSM456351                                                                                Primary hepatocytes Control for HepaRG           Human

cells-08-01117-t003_Table 3

###### 

List of human and mouse genes in quiescent and activated BECs.

  HUMAN      MOUSE                                                                  HUMAN/MOUSE                                                          
  ---------- ---------------------------------------------------------------------- ------------- ----------------- --------------- -------------------- -------------------------
  AKAP7      A-kinase anchoring protein 7                                           9465          ENSG00000118507   Akap7           ENSMUSG00000039166   Activated
  ALDH1A2    aldehyde dehydrogenase 1 family member A2                              8854          ENSG00000128918   Aldh1a2         ENSMUSG00000013584   Quiescent
  ANKRD1     ankyrin repeat domain 1                                                27063         ENSG00000148677   Ankrd1          ENSMUSG00000024803   Activated
  ANKRD42    ankyrin repeat domain 42                                               338699        ENSG00000137494   Ankrd42         ENSMUSG00000041343   Activated
  ARL14      ADP ribosylation factor like GTPase 14                                 80117         ENSG00000179674   Arl14           ENSMUSG00000098207   Quiescent and Activated
  ATF3       activating transcription factor 3                                      467           ENSG00000162772   Atf3            ENSMUSG00000026628   Quiescent
  B4GALT5    beta-1,4-galactosyltransferase 5                                       9334          ENSG00000158470   B4galt5         ENSMUSG00000017929   Activated
  BICC1      BicC family RNA binding protein 1                                      80114         ENSG00000122870   Bicc1           ENSMUSG00000014329   Quiescent and Activated
  C1orf116   chromosome 1 open reading frame 116                                    79098         ENSG00000182795   AA986860        ENSMUSG00000042510   Quiescent and Activated
  CDH1       cadherin 1                                                             999           ENSG00000039068   Cdh1            ENSMUSG00000000303   Activated
  CDH6       cadherin 6                                                             1004          ENSG00000113361   Cdh6            ENSMUSG00000039385   Activated
  CREB5      cAMP responsive element binding protein 5                              9586          ENSG00000146592   Creb5           ENSMUSG00000053007   Activated
  CRYAB      crystallin alpha B                                                     1410          ENSG00000109846   Cryab           ENSMUSG00000032060   Quiescent and Activated
  CTGF       connective tissue growth factor                                        1490          ENSG00000118523   Ctgf            ENSMUSG00000019997   Quiescent and Activated
  CYR61      cysteine rich angiogenic inducer 61                                    3491          ENSG00000142871   Cyr61           ENSMUSG00000028195   Quiescent and Activated
  DCDC2      doublecortin domain containing 2                                       51473         ENSG00000146038   Dcdc2a          ENSMUSG00000035910   Quiescent and Activated
  DDR1       discoidin domain receptor tyrosine kinase 1                            780           ENSG00000223680   Ddr1            ENSMUSG00000003534   Activated
  DSP        desmoplakin                                                            1832          ENSG00000096696   Dsp             ENSMUSG00000054889   Activated
  EGR2       early growth response 2                                                1959          ENSG00000122877   Egr2            ENSMUSG00000037868   Quiescent
  EHF        ETS homologous factor                                                  26298         ENSG00000135373   Ehf             ENSMUSG00000012350   Quiescent and Activated
  ELOVL7     ELOVL fatty acid elongase 7                                            79993         ENSG00000164181   Elovl7          ENSMUSG00000021696   Activated
  ENC1       ectodermal-neural cortex 1                                             8507          ENSG00000171617   Enc1            ENSMUSG00000041773   Activated
  ENTPD2     ectonucleoside triphosphate diphosphohydrolase 2                       954           ENSG00000054179   Entpd2          ENSMUSG00000015085   Quiescent
  EPCAM      epithelial cell adhesion molecule                                      4072          ENSG00000119888   Epcam           ENSMUSG00000045394   Quiescent and Activated
  FBRS       fibrosin                                                               64319         ENSG00000156860   Fbrs            ENSMUSG00000042423   Activated
  FLRT3      fibronectin leucine rich transmembrane protein 3                       23767         ENSG00000125848   Flrt3           ENSMUSG00000051379   Quiescent and Activated
  FOSB       FosB proto-oncogene, AP-1 transcription factor subunit                 2354          ENSG00000125740   Fosb            ENSMUSG00000003545   Quiescent and Activated
  FOXJ1      forkhead box J1                                                        2302          ENSG00000129654   Foxj1           ENSMUSG00000034227   Activated
  FRAS1      Fraser extracellular matrix complex subunit 1                          80144         ENSG00000138759   Fras1           ENSMUSG00000034687   Quiescent
  GADD45B    growth arrest and DNA damage inducible beta                            4616          ENSG00000099860   Gadd45b         ENSMUSG00000015312   Activated
  GLIS2      GLIS family zinc finger 2                                              84662         ENSG00000274636   Glis2           ENSMUSG00000014303   Quiescent and Activated
  GLIS3      GLIS family zinc finger 3                                              169792        ENSG00000107249   Glis3           ENSMUSG00000052942   Quiescent and Activated
  GOLGB1     golgin B1                                                              2804          ENSG00000173230   Golgb1          ENSMUSG00000034243   Quiescent
  HBEGF      heparin binding EGF like growth factor                                 1839          ENSG00000113070   Hbegf           ENSMUSG00000024486   Quiescent and Activated
  HSPA1A     heat shock protein family A (Hsp70) member 1A                          3303          ENSG00000237724   Hspa1a          ENSMUSG00000091971   Quiescent
  HSPA1B     heat shock protein family A (Hsp70) member 1B                          3304          ENSG00000224501   Hspa1b          ENSMUSG00000090877   Quiescent
  ITGB4      integrin subunit beta 4                                                3691          ENSG00000132470   Itgb4           ENSMUSG00000020758   Activated
  ITGB8      integrin subunit beta 8                                                3696          ENSG00000105855   Itgb8           ENSMUSG00000025321   Quiescent and Activated
  JUNB       JunB proto-oncogene, AP-1 transcription factor subunit                 3726          ENSG00000171223   Junb            ENSMUSG00000052837   Activated
  JUND       JunD proto-oncogene, AP-1 transcription factor subunit                 3727          ENSG00000130522   Jund            ENSMUSG00000071076   Quiescent and Activated
  KIAA1324   KIAA1324                                                               57535         ENSG00000116299   5330417C22Rik   ENSMUSG00000040412   Quiescent and Activated
  KLF5       Kruppel like factor 5                                                  688           ENSG00000102554   Klf5            ENSMUSG00000005148   Quiescent and Activated
  KRT17      keratin 17                                                             3872          ENSG00000128422   Krt17           ENSMUSG00000035557   Activated
  KRT19      keratin 19                                                             3880          ENSG00000171345   Krt19           ENSMUSG00000020911   Quiescent and Activated
  KRT7       keratin 7                                                              3855          ENSG00000135480   Krt7            ENSMUSG00000023039   Quiescent and Activated
  LAMB2      laminin subunit beta 2                                                 3913          ENSG00000172037   Lamb2           ENSMUSG00000052911   Quiescent
  LAMC2      laminin subunit gamma 2                                                3918          ENSG00000058085   Lamc2           ENSMUSG00000026479   Quiescent and Activated
  LRRC49     leucine rich repeat containing 49                                      54839         ENSG00000137821   Lrrc49          ENSMUSG00000047766   Activated
  MACC1      MET transcriptional regulator MACC1                                    346389        ENSG00000183742   Macc1           ENSMUSG00000041886   Quiescent and Activated
  MAGI1      membrane associated guanylate kinase, WW and PDZ domain containing 1   9223          ENSG00000151276   Magi1           ENSMUSG00000045095   Quiescent and Activated
  MYO5C      myosin VC                                                              55930         ENSG00000128833   Myo5c           ENSMUSG00000033590   Activated
  MYO6       myosin VI                                                              4646          ENSG00000196586   Myo6            ENSMUSG00000033577   Activated
  NFAT5      nuclear factor of activated T cells 5                                  10725         ENSG00000102908   Nfat5           ENSMUSG00000003847   Activated
  NFE2L3     nuclear factor, erythroid 2 like 3                                     9603          ENSG00000050344   Nfe2l3          ENSMUSG00000029832   Quiescent
  NFKBIE     NFKB inhibitor epsilon                                                 4794          ENSG00000146232   Nfkbie          ENSMUSG00000023947   Activated
  NOTCH2     notch 2                                                                4853          ENSG00000134250   Notch2          ENSMUSG00000027878   Quiescent and Activated
  NSD1       nuclear receptor binding SET domain protein 1                          64324         ENSG00000165671   Nsd1            ENSMUSG00000021488   Quiescent and Activated
  PEG10      paternally expressed 10                                                23089         ENSG00000242265   Peg10           ENSMUSG00000092035   Activated
  POGZ       pogo transposable element derived with ZNF domain                      23126         ENSG00000143442   Pogz            ENSMUSG00000038902   Activated
  PPP1R9A    protein phosphatase 1 regulatory subunit 9A                            55607         ENSG00000158528   Ppp1r9a         ENSMUSG00000032827   Activated
  RAI2       retinoic acid induced 2                                                10742         ENSG00000131831   Rai2            ENSMUSG00000043518   Quiescent and Activated
  RASSF9     Ras association domain family member 9                                 9182          ENSG00000198774   Rassf9          ENSMUSG00000044921   Quiescent and Activated
  RBM25      RNA binding motif protein 25                                           58517         ENSG00000119707   Rbm25           ENSMUSG00000010608   Activated
  RIPK4      receptor interacting serine/threonine kinase 4                         54101         ENSG00000183421   Ripk4           ENSMUSG00000005251   Activated
  S100A6     S100 calcium binding protein A6                                        6277          ENSG00000197956   S100a6          ENSMUSG00000001025   Quiescent and Activated
  SERPINH1   serpin family H member 1                                               871           ENSG00000149257   Serpinh1        ENSMUSG00000070436   Quiescent
  SF1        splicing factor 1                                                      7536          ENSG00000168066   Sf1             ENSMUSG00000024949   Activated
  SHROOM3    shroom family member 3                                                 57619         ENSG00000138771   Shroom3         ENSMUSG00000029381   Quiescent and Activated
  SLC5A1     solute carrier family 5 member 1                                       6523          ENSG00000100170   Slc5a1          ENSMUSG00000011034   Quiescent and Activated
  SLC6A6     solute carrier family 6 member 6                                       6533          ENSG00000131389   Slc6a6          ENSMUSG00000030096   Activated
  SLC7A1     solute carrier family 7 member 1                                       6541          ENSG00000139514   Slc7a1          ENSMUSG00000041313   Activated
  SLCO3A1    solute carrier organic anion transporter family member 3A1             28232         ENSG00000176463   Slco3a1         ENSMUSG00000025790   Activated
  SNRNP200   small nuclear ribonucleoprotein U5 subunit 200                         23020         ENSG00000144028   Snrnp200        ENSMUSG00000003660   Activated
  SNRNP70    small nuclear ribonucleoprotein U1 subunit 70                          6625          ENSG00000104852   Snrnp70         ENSMUSG00000063511   Quiescent and Activated
  SOX9       SRY-box 9                                                              6662          ENSG00000125398   Sox9            ENSMUSG00000000567   Quiescent and Activated
  SPHK1      sphingosine kinase 1                                                   8877          ENSG00000176170   Sphk1           ENSMUSG00000061878   Activated
  SPINT1     serine peptidase inhibitor, Kunitz type 1                              6692          ENSG00000166145   Spint1          ENSMUSG00000027315   Quiescent and Activated
  SREBF2     sterol regulatory element binding transcription factor 2               6721          ENSG00000198911   Srebf2          ENSMUSG00000022463   Activated
  STK35      serine/threonine kinase 35                                             140901        ENSG00000125834   Stk35           ENSMUSG00000037885   Activated
  SYNJ2      synaptojanin 2                                                         8871          ENSG00000078269   Synj2           ENSMUSG00000023805   Quiescent and Activated
  TACSTD2    tumor associated calcium signal transducer 2                           4070          ENSG00000184292   Tacstd2         ENSMUSG00000051397   Activated
  TCF20      transcription factor 20                                                6942          ENSG00000100207   Tcf20           ENSMUSG00000041852   Activated
  TGFB2      transforming growth factor beta 2                                      7042          ENSG00000092969   Tgfb2           ENSMUSG00000039239   Quiescent and Activated
  THSD4      thrombospondin type 1 domain containing 4                              79875         ENSG00000187720   Thsd4           ENSMUSG00000032289   Activated
  TNFRSF19   TNF receptor superfamily member 19                                     55504         ENSG00000127863   Tnfrsf19        ENSMUSG00000060548   Activated
  TUBB2B     tubulin beta 2B class IIb                                              347733        ENSG00000137285   Tubb2b          ENSMUSG00000045136   Activated
  UBAP2L     ubiquitin associated protein 2 like                                    9898          ENSG00000143569   Ubap2l          ENSMUSG00000042520   Quiescent and Activated
  UGT8       UDP glycosyltransferase 8                                              7368          ENSG00000174607   Ugt8a           ENSMUSG00000032854   Quiescent and Activated
  UNC119B    unc-119 lipid binding chaperone B                                      84747         ENSG00000175970   Unc119b         ENSMUSG00000046562   Activated
  VTCN1      V-set domain containing T cell activation inhibitor 1                  79679         ENSG00000134258   Vtcn1           ENSMUSG00000051076   Activated
  WFDC2      WAP four-disulfide core domain 2                                       10406         ENSG00000101443   Wfdc2           ENSMUSG00000017723   Activated
  WWC1       WW and C2 domain containing 1                                          23286         ENSG00000113645   Wwc1            ENSMUSG00000018849   Quiescent and Activated
  ZFP36      ZFP36 ring finger protein                                              7538          ENSG00000128016   Zfp36           ENSMUSG00000044786   Activated
  ZFP36L1    ZFP36 ring finger protein like 1                                       677           ENSG00000185650   Zfp36l1         ENSMUSG00000021127   Activated
